Table 5 Final model of primary outcome, treatment success
Model effects | Parameter estimate | Wald 95% CI | pvalue |
|---|---|---|---|
Intercept | 0.363 | −0.400–1.126 | 0.352 |
Trial arm | |||
PALM PLUS and | |||
LHW intervention | −0.900 | −1.920–0.120 | 0.084 |
PALM PLUS alone | −0.468 | −1.486–0.551 | 0.368 |
TB type | |||
Non-pulmonary TB | −1.065 | −1.815 to −0.314 | 0.005 |
Trial arm × TB type | |||
PALM PLUS and LHW intervention × non-pulmonary | 1.312 | 0.341–2.283 | 0.008 |
PALM PLUS alone × non-pulmonary | 0.435 | −0.850–1.719 | 0.507 |
Gender | |||
Female | −0.636 | −1.006 to −0.267 | 0.001 |